• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: symptom improvement does not equal satisfaction with treatment for constipation-authors' reply.

作者信息

Basilisco Guido, Barbara Giovanni, Bellini Massimo, Cataudella Giovanni, D'Alba Lucia, Guarino Michele, Iovino Paola, Neri Maria Cristina, Sarnelli Giovanni, Savarino Edoardo, Tolone Salvatore, Torresan Francesco, Usai-Satta Paolo, Lovati Ambra, Arsiè Elena, Coletta Marina

机构信息

Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Department of Medical and Surgical Sciences, Sant'Orsola Malpighi Hospital, Bologna, Italy.

出版信息

Aliment Pharmacol Ther. 2020 May;51(9):910-911. doi: 10.1111/apt.15697.

DOI:10.1111/apt.15697
PMID:32285509
Abstract
摘要

相似文献

1
Editorial: symptom improvement does not equal satisfaction with treatment for constipation-authors' reply.社论：症状改善并不等同于对便秘治疗的满意度——作者回复
Aliment Pharmacol Ther. 2020 May;51(9):910-911. doi: 10.1111/apt.15697.
2
Editorial: symptom improvement does not equal satisfaction with treatment for constipation.社论：症状改善并不等同于对便秘治疗的满意度。
Aliment Pharmacol Ther. 2020 May;51(9):909-910. doi: 10.1111/apt.15683.
3
Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? Authors' reply.
Aliment Pharmacol Ther. 2017 Oct;46(7):698-699. doi: 10.1111/apt.14260.
4
Editorial: differentiating chronic idiopathic constipation from constipation-predominant irritable bowel syndrome--possible and important?--Authors' reply.
Aliment Pharmacol Ther. 2015 Jun;41(12):1300. doi: 10.1111/apt.13219.
5
Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.肠易激综合征改善的预测因素：400例患者的1年前瞻性评估
Aliment Pharmacol Ther. 2006 Mar 15;23(6):815-26. doi: 10.1111/j.1365-2036.2006.02828.x.
6
A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.一项针对西班牙中重度便秘型肠易激综合征社会经济负担的回顾性和前瞻性12个月观察性研究。
Gastroenterol Hepatol. 2019 Mar;42(3):141-149. doi: 10.1016/j.gastrohep.2018.10.008. Epub 2019 Jan 3.
7
Editorial: the overlap of atopy and functional gastrointestinal disorders in primary care--authors' reply.社论：基层医疗中特应性与功能性胃肠疾病的重叠——作者回复
Aliment Pharmacol Ther. 2014 Nov;40(10):1244-5. doi: 10.1111/apt.12961.
8
Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome.含与不含替加色罗的缓泻剂对以便秘为主型肠易激综合征青少年的影响。
Aliment Pharmacol Ther. 2006 Jan 1;23(1):191-6. doi: 10.1111/j.1365-2036.2006.02705.x.
9
Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype.与鲁比前列酮治疗肠易激综合征便秘亚型相关的治疗模式、症状减轻、生活质量及资源利用情况
Curr Med Res Opin. 2016 May;32(5):899-905. doi: 10.1185/03007995.2016.1150262. Epub 2016 Mar 11.
10
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.替加色罗用于治疗肠易激综合征和慢性便秘。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD003960. doi: 10.1002/14651858.CD003960.pub3.

引用本文的文献

1
Positive Treatment Expectations Shape Perceived Medication Efficacy in a Translational Placebo Paradigm for the Gut-Brain Axis.在肠道-脑轴的转化性安慰剂范式中，积极的治疗期望塑造了对药物疗效的感知。
Front Psychiatry. 2022 Mar 24;13:824468. doi: 10.3389/fpsyt.2022.824468. eCollection 2022.